← back to search

Matthew Loose

University of Nottingham · GB
🔎 Find collaborators in Molecular Biology · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Genomics and Phylogenetic Studies, SARS-CoV-2 and COVID-19 Research, RNA modifications and cancer, and SARS-CoV-2 detection and testing.
h-index
45
citations
15,612
works
205
NIH funding
primary concept
Biology
email

Recent publications

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
Nature Medicine 2025cited by 36position: middledoi
ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis
Neuro-Oncology 2025cited by 12position: lastdoi
ROBIN: A unified nanopore-based sequencing assay integrating real-time, intraoperative methylome classification and next-day comprehensive molecular brain tumour profiling for ultra-rapid tumour diagnostics
medRxiv 2024cited by 9position: lastdoi
Versatile, accessible cross-platform molecular profiling of central nervous system tumors: web-based, prospective multi-center validation
Research Square 2024cited by 3position: middledoi
Genomics and biochemical analyses reveal a metabolon key to β-L-ODAP biosynthesis in Lathyrus sativus
Nature Communications 2023cited by 35position: middledoi
PATH-64. COMPREHENSIVE CNS TUMOUR MOLECULAR DIAGNOSTICS USING THIRD GENERATION SEQUENCING
Neuro-Oncology 2023cited by 1position: middledoi
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study
Acta Neuropathologica 2022cited by 72position: middledoi
Genetic variation at mouse and human ribosomal DNA influences associated epigenetic states
Genome biology 2022cited by 40position: middledoi
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Nature Communications 2022cited by 18position: middledoi
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study
eLife 2022cited by 16position: middledoi
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning
Scientific Reports 2022cited by 11position: middledoi
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Cell Reports 2021cited by 448position: middledoi
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
The Lancet Public Health 2021cited by 343position: middledoi
P07.04 Rapid-CNS2: Rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof of concept study
Neuro-Oncology 2021cited by 4position: middledoi
Genetic variation at mouse and human ribosomal DNA influences associated epigenetic states
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 2position: middledoi
PATH-48. RAPID-CNS2: RAPID COMPREHENSIVE ADAPTIVE NANOPORE-SEQUENCING OF CNS TUMORS, A PROOF OF CONCEPT STUDY
Neuro-Oncology 2021cited by 1position: middledoi
Rapid-CNS <sup>2</sup> : Rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof of concept study
medRxiv 2021cited by 1position: middledoi
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Cell 2020cited by 1,082position: middledoi
Telomere-to-telomere assembly of a complete human X chromosome
Nature 2020cited by 826position: middledoi
Nanopore native RNA sequencing of a human poly(A) transcriptome
Nature Methods 2019cited by 737position: middledoi
Nanopore sequencing and assembly of a human genome with ultra-long reads
Nature Biotechnology 2018cited by 2,089position: lastdoi
Establishment and cryptic transmission of Zika virus in Brazil and the Americas
Nature 2017cited by 664position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nadine Holmes · University of Nottingham7 papers (2019–2025)Areeba Patel · German Cancer Research Center6 papers (2021–2025)Felix Sahm · Heidelberg (Poland)6 papers (2021–2025)Wolfgang Wick · Heidelberger Institut für Radioonkologie4 papers (2021–2023)Martin Sill · German Cancer Research Center4 papers (2021–2023)David Jones · Mayo Clinic in Florida4 papers (2021–2023)Helin Dogan · German Cancer Research Center4 papers (2021–2023)Stefan M. Pfister · Université du Québec4 papers (2021–2023)Alexander Payne · University of Nottingham4 papers (2019–2023)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen4 papers (2021–2023)Matthias Schlesner · University of Augsburg3 papers (2021–2023)Christel Herold‐Mende · German Cancer Research Center3 papers (2021–2021)Daniel Schrimpf · German Cancer Research Center3 papers (2021–2023)Violaine Rosenstiel-Goidts · German Cancer Research Center2 papers (2021–2021)Alan Hodgkinson · King's College London2 papers (2021–2022)Stuart Smith · University of Nottingham2 papers (2024–2025)Christoph Dieterich · DKFZ-ZMBH Alliance2 papers (2021–2021)Amy F. Danson · Queen Mary University of London2 papers (2021–2022)Natalie Schoebe · German Cancer Research Center2 papers (2021–2021)Mark Housley · University of Nottingham2 papers (2024–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Infectious Diseases →